Related Experiment Video
Updated: May 6, 2026
07:32
Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
Published on: March 16, 2015
16.3K
[Gene therapy for human hearing loss: challenges and promises]
Anaïs Meyer1, Christine Petit, Saaid Safieddine
1Institut Pasteur, unité de génétique et physiologie de l'audition, 25, rue du Docteur Roux, 75724 Paris Cedex 15, France - Inserm UMRS 1120, 75015 Paris, France.
Medecine Sciences : M/S
|October 24, 2013
Summary
Recent advances in genomics have identified deafness genes and created animal models, paving the way for gene therapy to treat hearing loss. Challenges remain before clinical application.
Area of Science:
- Genomics and molecular biology
- Otolaryngology
- Auditory neuroscience
Context:
- Human genomics advances over 20 years have significantly improved understanding of deafness pathogenesis.
- Identification of deafness genes and development of murine models have advanced knowledge of auditory sensory cell physiology.
- Milestones enable new therapeutic strategies beyond conventional prostheses and cochlear implants.
Purpose:
- To review progress in gene therapy and antisense RNA delivery for deafness over the last decade.
- To discuss the potential of gene therapy for acquired and inherited deafness.
- To identify major obstacles for clinical application of gene therapy in hearing restoration.
Summary:
- Gene therapy and antisense RNA delivery show promise for treating hearing loss.
- New methods for cochlear gene transfer are being developed.
- Overcoming obstacles is crucial for translating gene therapy to clinical practice.
Impact:
- Gene therapy offers potential alternatives to current hearing loss treatments.
- Advances in gene transfer methods are crucial for therapeutic success.
- Further research is needed to overcome challenges for widespread clinical use.
Related Concept Videos
00:59Gene Therapy
22.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.3K
00:59Gene Therapy
4.5K
4.5K
01:31Hearing
48.1K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
48.1K
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
00:50Unrenewable Cells
2.1K
In humans, the photoreceptor cells of the eye and sensory hair cells of the ear lack stem cells. These cells are thus unrenewable and cannot be replaced when they are damaged or destroyed.
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
2.1K